Jeffrey Ha
banner
jeffreyha.bsky.social
Jeffrey Ha
@jeffreyha.bsky.social
Nephrologist
#cardiorenal #CKM syndrome
Postdoc @georgeinstitute.bsky.social @UNSWMedicine Sydney, Australia
@ajkd.bsky.social intern 22/23
We also recently transitioned a pt to both - incremental HDF 💧💦 Some are very CONVINCEd in our dept but we may INCH closer to finding an answer #AKTN aktn.org.au/inch-hd/ pubmed.ncbi.nlm.nih.gov/36938090/ @sarahkmels.bsky.social @nephmadness.bsky.social
INCH-HD - Australasian Kidney Trials Network (AKTN)
The INCremental dialysis to improve Health outcomes in people starting Haemodialysis (INCH-HD) study: a randomised controlled trial
aktn.org.au
March 21, 2025 at 9:07 PM
Reposted by Jeffrey Ha
This is from a Bayer funded (but not Bayer influenced) @ndt-era.bsky.social supplement on trials and combination therapies in CKD

With really good reviews from experts incl @brendonneuen.bsky.social and many more

academic.oup.com/ndt/issue/40...

#NephSky
Volume 40 Issue Supplement_1 | Nephrology Dialysis Transplantation | Oxford Academic
An official journal of the European Renal Association - European Dialysis and Transplant Association. Publishes peer-reviewed original clinical and laboratory research across the full range of nephrol...
academic.oup.com
February 16, 2025 at 1:52 AM
Reposted by Jeffrey Ha
Are you using HIF-PHIs?

(I would love to try in predialysis and PD mostly, but the companies didn’t even bother coming to 🇨🇦)

(Disclosure we wrote this: evidence.nejm.org/doi/abs/10.1... mostly Jeff Ha and @sunilbadve.bsky.social )
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney Disease
Hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors are an oral treatment for anemia of chronic kidney disease (CKD). In this systematic review and meta-analysis, we assessed long-term saf...
evidence.nejm.org
November 21, 2024 at 11:25 AM